Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ccros
    Junior Member
    • Mar 2015
    • 3

    #1

    Annotating 3' UTR in the central nervous system

    Hi,
    I am interested in identifying 5' UTR and 3' UTR of known mouse genes linked to olfaction. I have access to the CDS, poor annotations of the 5' and 3' from Biomart, CAGE data for the promoters and lots of RNASeq data (10 samples with 30-80M reads, paired-end but unstranded) from the litterature.

    I have read (Widespread and extensive lengthening of 3' UTRs in the mammalian brain Miura 2013) that in the CNS there are longer 3' isoforms, often tied to local transport and translation in dendrites or axons.
    Do you know what type of tissue is used for 'official' annotations (mm10 for example) done with RNA Seq data? In IGV I see very different types of 3' UTR in the olfactory epithelium, but this could be a tissue specific thing.

    What would you use for annotating 3'UTR?
    I am thinking of trying out IsoSCM (Jan2015, Shenker), but is very recent. I have also heard some good about TrinityRNASeq. Cufflinks is rather bad for this task, it missed isoforms I could see on IGV (and then confirmed with Northern Blots).

    Thanks a lot for your help.
    Cyril
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    The official annotations are typically from a mix of different tissues, since they end up being drawn from databases of observed transcripts. In my mouse brain RNAseq samples, I almost always see longer 3'UTRs than exist in the Ensembl/UCSC/etc. annotations. I have primarily hippocampal samples, so I wouldn't expect much coverage of the receptors you're interested (so I can't offer much insight into them).

    One common method if you absolutely need the UTRs is to simply run cufflinks on the samples followed by cuffmerge with the reference annotation. I've tried that in the past and it seems to work fine (not that it changed the results of the down stream statistics much, though perhaps it will for you).

    Comment

    • ccros
      Junior Member
      • Mar 2015
      • 3

      #3
      Thanks for the answer.
      So far, IsoSCm has given me greatly improved 3' UTRs. There are quite a few options to set. For example, short introns (<100) seems to be ignored in 3' UTR.
      I also note that new software (early 2015) such as Kleat and other de novo transcriptome assembly tools offer the same features.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      40 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...